Quince Therapeutics (QNCX) Debt Ratio (2023 - 2025)

Quince Therapeutics has reported Debt Ratio for 3 years, with the latest figure at 0.19 in Q4 2025.

• On a quarterly basis, Debt Ratio rose 54.07% year-over-year to 0.19 in Q4 2025; TTM through Dec 2025 was 0.19, a 54.07% increase from a year earlier, with the FY2025 full-year figure at 0.19, up 54.07% from the prior year.
• Debt Ratio was 0.19 for Q4 2025 at Quince Therapeutics, up from 0.16 in the prior quarter.
• The five-year high for Debt Ratio was 0.19 in Q4 2025, with the low at 0.1 in Q4 2023.
• Average Debt Ratio over 3 years is 0.14, with a median of 0.13 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio advanced 19.8% in 2024, then surged 54.07% in 2025.
• Over 3 years, Debt Ratio stood at 0.1 in 2023, then climbed by 19.8% to 0.13 in 2024, then surged by 54.07% to 0.19 in 2025.
• The last three Debt Ratio figures came in at 0.19 (Q4 2025), 0.16 (Q3 2025), and 0.14 (Q1 2025), per Business Quant data.